Recombinetics
Pre-clinicalRecombinetics is a recognized leader in animal gene editing and associated applied technologies for biomedical research, regenerative medicine and animal agriculture.
Founded
2008
Focus
Genetics & GenomicsCRISPRSynthetic Biology
About
Recombinetics is a recognized leader in animal gene editing and associated applied technologies for biomedical research, regenerative medicine and animal agriculture.
Funding History
3Total raised: $54.5M
Grant$500KNational Institutes of HealthMar 15, 2021
Series B$20MKensington Capital PartnersFeb 15, 2020
Series A$34MKensington Capital PartnersJun 15, 2018
Company Info
TypePrivate
Founded2008
LocationSaint Paul, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile